Teva Pharmaceutical Industries has
announced that Teva and the Procter & Gamble Company have agreed to
terminate the PGT Healthcare partnership that the two companies established in
2011 to market OTC (Over The Counter) medicines. The separation is planned to
take effect July 1, 2018 subject to receipt of applicable regulatory approvals.